Pharmacological alternatives to Antipsychotics in the Management of BPSD
Abstract
In this review, we will discuss the evidence and provide an update on the pharmacological treatments of Behavioural and Psychological symptoms of Dementia (BPSD) especially anti-psychotic medications. Non-pharmacological management of BPSD remains the initial treatment for BPSD; however, pharmacological management have a role in specific situations. This review should support the management of elderly inpatients suffering from Dementia and challenging behaviour in mental health units, general hospitals, community settings and care homes. It will help in raising awareness to the risk of complications such as stroke/death associated with first and second generation antipsychotic medications. It will also highlight some issues in relation to the current guidelines and licensing in the USA, UK and Europe. Good clinical practice used in the management of BPSD to reduce the risk of stroke and other complications is included.Citation
Mishriky, R., & Reyad, A.A. (2018). Pharmacological alternatives to antipsychotics to manage BPSD. Progress in Neurology and Psychiatry, 22 (1), pp 30-35.Publisher
WileyJournal
Progress in Neurology and PsychiatryDOI
10.1002/pnp.495Additional Links
https://onlinelibrary.wiley.com/doi/abs/10.1002/pnp.495Type
Journal articleLanguage
enISSN
1367-7543ae974a485f413a2113503eed53cd6c53
10.1002/pnp.495
Scopus Count
Collections
The following licence applies to the copyright and re-use of this item:
- Creative Commons
Except where otherwise noted, this item's license is described as https://creativecommons.org/CC BY-NC-ND 4.0